Browse grants

National Institutes of Health · Amount varies

This NIH/NCI R01 funds advanced preclinical research translating nanotechnology-based cancer diagnostics and therapeutics toward later NCI translational programs; no clinical trial is allowed. Eligible applicants are research and education institutions, including minority-serving and tribal-serving institutions, faith- or community-based organizations, and tribal governments; it targets research organizations, not individuals. Foreign organizations are not eligible. No award amount is specified, and the nanomedicine focus makes the scope narrow.

National Institutes of Health · Up to $6.3M

This NIH award lets investigators use NICHD's existing clinical research network infrastructure to run multisite trials and studies on infant, child, women's, and disability health, structured as a start-up phase followed by full enrollment. Applications must be submitted jointly with an NICHD-supported network Data Coordinating Center, which narrows this to investigators already positioned within that network. Awards can reach up to $6,250,000.

National Institutes of Health · Up to $100K

This NIH (R03) opportunity funds pilot projects generating preliminary data on a defined list of understudied proteins associated with rare diseases. It is intended for research and academic institutions; foreign organizations are not eligible to apply. The maximum award is about $100,000.

National Institutes of Health · Amount varies

This NIDDK (R21) opportunity funds basic and translational pilot research on biological, behavioral, and social mechanisms contributing to HIV pathogenesis within NIDDK's mission. It is intended for research and academic institutions; foreign organizations are not eligible to apply. No specific award amount is stated.

National Institutes of Health · Up to $200K

This NIH (R21) opportunity funds research developing novel screening approaches or therapies for fatal or disabling conditions identified through newborn screening, including high-priority genetic conditions. It is intended for research and academic institutions rather than individuals or general nonprofits/small businesses. The maximum award is about $200,000.

National Institutes of Health · Amount varies

This NIH (R01) opportunity funds research developing novel screening approaches or therapies for fatal or disabling conditions identified through newborn screening, including high-priority genetic conditions. It is intended for research and academic institutions rather than individuals or general nonprofits/small businesses. No specific award amount is stated.

National Institutes of Health · Amount varies

This NIH (R21) opportunity funds basic, mechanistic research into the biological and genetic causes of cancer health disparities, including new methods, models, and secondary data analyses. It is intended for research and academic institutions rather than individuals or general nonprofits/small businesses. No specific award amount is stated.

National Institutes of Health · Up to $300K

This NIH (R01) opportunity funds basic research into the harmful effects of acute exposure to ultra-potent synthetic opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations, including delayed effects. It is aimed at research and academic institutions; foreign organizations are not eligible to apply. The maximum award is about $300,000.

Dept of the Army -- Materiel Command · Amount varies

This U.S. Army Research Laboratory Broad Agency Announcement solicits foundational (basic and applied) research proposals supporting Army modernization. Eligibility is broad, including universities, nonprofits, state and local governments, foreign organizations, and for-profit firms (large and small businesses). It uses a competitive merit-based process; no specific award amount is stated.

National Institutes of Health · Amount varies

This NIH (R01) opportunity funds innovative analysis of existing social, behavioral, administrative, and neuroimaging datasets to study substance-use behaviors, related disorders, prevention, and health-service use. It is intended for research and academic institutions rather than individuals or general nonprofits/small businesses. No specific award amount is stated.

National Institutes of Health · Amount varies

This NIH (R21) opportunity funds innovative analysis of existing social, behavioral, administrative, and neuroimaging datasets to study substance-use behaviors, related disorders, prevention, and health-service use. It is intended for research and academic institutions rather than individuals or general nonprofits/small businesses. No specific award amount is stated.

National Institutes of Health · Amount varies

This NHLBI Catalyze (R61/R33) phased opportunity funds medical device prototype design and testing, disease-target identification, and assay development for heart, lung, blood, and sleep diseases. It is aimed at research and academic institutions; foreign organizations are not eligible to apply. No specific award amount is stated.

National Institutes of Health · Amount varies

This NHLBI Catalyze (R33) opportunity funds early-stage translational work to optimize medical device prototypes, develop diagnostic assays, and create research tools for heart, lung, blood, and sleep diseases. It is aimed at research and academic institutions; foreign organizations are not eligible to apply. No specific award amount is stated.

National Institutes of Health · Up to $350K

This NHLBI Catalyze (R33) opportunity funds rigorous validation of transformative, multi-use platforms or technologies that can advance detection, diagnosis, treatment, or prevention of heart, lung, blood, and sleep diseases. It is aimed at research and academic institutions; foreign organizations are not eligible to apply. The maximum award is about $350,000.

National Institutes of Health · Amount varies

This NHLBI Catalyze (R61/R33) phased opportunity funds target identification and validation plus preliminary product or lead-series identification for small molecules, biologics, and combination products treating heart, lung, blood, and sleep diseases. It is aimed at research and academic institutions; foreign organizations are not eligible to apply. No specific award amount is stated.

National Institutes of Health · Amount varies

This NHLBI Catalyze (R33) opportunity funds early-stage translational work to identify and characterize therapeutic candidates and combination products (small molecules and biologics) for heart, lung, blood, and sleep diseases. It is aimed at research and academic institutions; foreign organizations are not eligible to apply. No specific award amount is stated.

Environmental Protection Agency · Up to $3M

This EPA program funds assessment and remediation of contaminated Alaska Native Claims Settlement Act lands, plus related community outreach. Eligibility is limited to Alaska Native regional and village corporations, federally recognized Tribes in Alaska, Alaska Native nonprofit associations, and inter-tribal consortia of Alaskan tribal entities. The maximum award is up to about $3,000,000, and proposals are accepted on a rolling basis; applicants are asked to contact program managers first.

National Park Service · Amount varies

This National Park Service opportunity offers Master Cooperative Agreements to participants in the Cooperative Ecosystem Studies Units (CESU) network across listed regions, supporting research, technical assistance, education, and capacity building. Only existing CESU network partners may apply, so applicants must already have joined the network. No specific award amount is provided.

Community & Economic Development · Amount varies

Open broadly to Pennsylvania municipalities, local authorities, nonprofits, and other legal entities. Funded through the state's gaming-derived Sports Marketing and Tourism Account, it supports attracting amateur, professional, and e-sports events to the Commonwealth to boost tourism and economic impact. Award amount isn't specified; applications are due December 31, 2027.

Dept of the Army -- Materiel Command · Amount varies

This U.S. Army DEVCOM Analysis Center Broad Agency Announcement solicits applied-research proposals supporting Army modernization, tool development, and data curation. Eligibility is broad, including universities, nonprofits, state and local governments, foreign organizations, and for-profit firms (large and small businesses). It uses a whitepaper-then-proposal process; no specific award amount is stated.